Feb 6, 2012

But polio stubbornly persists in pockets of poverty in Africa and Asia.

How we will eradicate the next polio

Recently, in San Diego, Microsoft Chairman Bill Gates and Rotary International announced a massive infusion of new money to finally eradicate polio worldwide. Polio is given little attention in American media today because it is no longer a public health issue in this country.
Decades ago, the deadly paralytic viral disease was purged from developed countries. But polio stubbornly persists in pockets of poverty in Africa and Asia.
Today the challenges to globally eliminating polio are largely political and cultural – overcoming local fears about vaccine safety, reaching people in war-torn areas, tracking people who are constantly moving and adequately strengthening the polio-fighting infrastructure.
We applaud Gates, Rotary and others for their enduring commitment to eradicating this viral menace that jeopardizes the health of poor children unlucky enough to be born in the slums of India, Afghanistan, Pakistan or Nigeria.
Of course, here at the Salk Institute we paid particular attention to the Gates/Rotary announcement because the original polio vaccine that halted the spread of the vicious disease was developed by our founder, Dr. Jonas Salk. Indeed, our highly regarded research institution owes its very existence to Salk's genius and persistence in conquering the poliovirus, and to the vision of the March of Dimes, which provided institute seed funding and continues to support our work.
For Americans too young to remember: Polio was once a public health terror, frightening families coast to coast. Each year thousands of children and teenagers died from polio outright. Many more, including President Franklin Delano Roosevelt, were severely crippled by it. Iron lungs, massive leg braces and wheelchairs were stark symbols of polio's life-altering effects.
The polio story deserves recalling because it is a shining example of innovation, dedication and resourcefulness in post-war America. Working under a mandate from FDR with public and private support and a great sense of urgency, scientists probed the biological properties of the polio virus. In 1948, the first breakthrough: Scientists in Boston successfully grew the virus in laboratory human tissue, facilitating vaccine research. Then, in Pittsburgh in 1952, Jonas Salk and his colleagues devised the first vaccine to boost immunity and show promise for large-scale use.
Our country then embarked on what, to this day, must be the most massive clinical testing ever. Some 1.8 million American children and teens were part of field trials in 44 states – from Maine to California. The study participants were dubbed “Polio Pioneers” and, whether they received the real vaccine, a placebo or were in the control group for comparison, each child was awarded a certificate attesting to his or her national contribution.
With testing on such an enormous scale, it rapidly became clear that the vaccine was both safe and effective. The trial was stopped in 1955 and the vaccine made available to the public.
Decades later Dr. Salk met an elderly man and his grandson in the Salk Institute courtyard. “There's the man who killed polio,” the grandfather told the boy. “What's polio?” the boy replied. Salk later described that moment as one of his proudest.

 “Polio Pioneers”

México a la vanguardia en el Síndrome de Post Polio

Polio Film


Entradas populares



México Post Polio Una Vida Un Camino Una Experiencia

Post Polio LITAFF A.C.

Postpoliolitaff.- Asociación Post Polio Litaff A.C Primera Organización oficial sobre Síndrome de Post Poliomielitis En México.

Polio y Efectos Secundarios SPP
- See more at: http://polioamigossinfronteras.blogspot.mx/#sthash.6PkHAkfM.dpuf


Salk Institute

Polio Video

Polio Lungs


Polio Reinders

March Of Dimes Polio History

Erradicación de La poliomielitis

Blog Archive

Search This Blog

No more Polio

Dr. Bruno